Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups

Psoriasis management in the rapidly expanding geriatric population can be complex due to frailty, comorbidities, comedication and limited available data on treating older psoriasis patients.1 Previous studies reported comparable disease severity in patients ≥65 years old (≥65yo) and patients <65yo,2-4 although prescribed antipsoriatic therapies differed between age groups.2,3,5 This might be due to comorbidities and comedication, and/or due to disease perception or patient preferences.3,5 Unfortunately, little is known regarding these topics in older psoriasis patients. Moreover, it has been suggested that currently available quality of life (QoL) assessment tools do not always appropriately reflect true QoL impairment in older adults.6.